| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO I SEK CAP | RVI EMERGENTES | 55,02% | 55,56% | 17,47% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 55,02% | 7,33% | -32,51% | · |
| BARINGS ASIA GROWTH FUND A USD INC | RVI ASIA EX-JAPÓN | 55,00% | 45,69% | 6,42% | 140,55% |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 EUR | TMT | 54,99% | 125,11% | 80,77% | 625,67% |
| TEMPLETON EMERGING MARKETS W (ACC) USD | RVI EMERGENTES | 54,99% | 74,58% | 41,23% | 177,35% |
| BARINGS ASIA GROWTH FUND A EUR INC | RVI ASIA EX-JAPÓN | 54,98% | 45,67% | 6,53% | 140,96% |
| SCHRODER ISF LATIN AMERICAN C DIS USD | RVI LATINOAMÉRICA | 54,98% | 32,29% | 30,03% | 63,14% |
| OAKTREE (LUX.) FUNDS - OAKTREE EMERGING MARKETS EQUITY RH EUR ACC | RVI EMERGENTES | 54,97% | 41,54% | 8,96% | 82,76% |
| BNP PARIBAS JAPAN SMALL CAP N CAP | RVI JAPÓN SMALL/MID CAP | 54,96% | 72,44% | 48,12% | 148,67% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 54,96% | 7,10% | -32,81% | · |
